Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,043,759 | 880,889 | 1,013,341 | 919,025 | 954,610 |
| Cost of Goods | 76,634 | 60,956 | 69,751 | 60,091 | 68,326 |
| Gross Profit | 967,125 | 819,933 | 943,590 | 858,934 | 886,284 |
| Operating Expenses | 1,445,889 | 728,991 | 757,071 | 644,320 | 692,830 |
| Operating Income | -478,130 | 91,898 | 187,270 | 214,705 | 193,780 |
| Interest Expense | 657 | 430 | 804 | 623 | 655 |
| Other Income | 89,010 | 144,691 | 84,490 | 19,717 | 84,479 |
| Pre-tax Income | -389,777 | 236,159 | 270,956 | 233,799 | 277,604 |
| Income Tax | 54,824 | 66,611 | 69,877 | 62,530 | 74,056 |
| Net Income Continuous | -444,601 | 169,548 | 201,079 | 171,269 | 203,548 |
| Net Income | $-444,601 | $169,548 | $201,079 | $171,269 | $203,548 |
| EPS Basic Total Ops | -2.04 | 0.76 | 0.90 | 0.76 | 0.91 |
| EPS Basic Continuous Ops | -2.04 | 0.76 | 0.90 | 0.76 | 0.91 |
| EPS Diluted Total Ops | -2.04 | 0.75 | 0.89 | 0.76 | 0.90 |
| EPS Diluted Continuous Ops | -2.04 | 0.75 | 0.89 | 0.76 | 0.90 |
| EPS Diluted Before Non-Recurring Items | -2.03 | 0.38 | 0.82 | 0.91 | 0.77 |
| EBITDA(a) | $-456,082 | $113,845 | $209,032 | $236,095 | $214,077 |